A drug store tech pours out pills of hydroxychloroquine at Rock Canyon Drug Store in Provo, Utah, on May 20, 2020.
GEORGE FREY/Getty Images
Slate is making its coronavirus protection free for all readers. Register for support our journalism. Start your free trial
The World Health Organization is pushing time out on its trial of hydroxychloroquine as treatment for COVID-19 out of fear for the drug’s possible danger The medication best understood for its use against malaria and autoimmune conditions has actually been at the heart of debate as President Donald Trump, to name a few, has actually promoted its usage to eliminate the coronavirus. But WHO Director-General Tedros Adhanom Ghebreyesus informed reporters at a news rundown Monday that the organization would temporarily suspend its trial of the drug over safety concerns.
The research study found that those who took hydroxychloroquine or its related drug chloroquine were more likely to pass away or establish an irregular heart rhythm “The executive group has carried out a momentary pause of the hydroxychloroquine arm within the Solidarity Trial while the safety information is evaluated by the information safety tracking board. The other arms of the trial are continuing,” Tedros said.